
|Articles|November 23, 2022
Incyte Biosciences United Kingdom and Ireland Appoints Peter Williams As General Manager
Advertisement
Incyte announces the appointment of Peter Williams as General Manager for Incyte Biosciences United Kingdom and Ireland. In his role, Peter will be responsible for the development of medical, regulatory and commercial strategy for Incyte’s portfolio of products in the UK and Ireland.
“On behalf of our leadership team, I would like to welcome Peter to Incyte. His extensive commercial experience will greatly enhance the teams in the UK & Ireland and support our continued growth,” said Jonathan Dickinson, Executive Vice President and General Manager for Incyte Europe.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
3
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
4
Taming the Complexity of CGT Commercialization: 5 Keys to a Workable Operating Model
5




